FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19371411000001104: Iasibon 50mg tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Aug 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65330101000001119 Iasibon 50mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65330201000001114 Iasibon 50mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Iasibon 50mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Is a Ibandronic acid 50mg tablets true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Is a Ibandronic acid 50mg tablets false Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Is a Product containing precisely ibandronic acid 50 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has active ingredient Ibandronic acid false Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has specific active ingredient Ibandronic sodium monohydrate false Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Is a Iasibon true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Iasibon 50mg tablets (Aspire Pharma Ltd) Has specific active ingredient Ibandronate sodium monohydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Iasibon 50mg tablets (Aspire Pharma Ltd) 28 tablet 4 x 7 tablets Has AMP True Iasibon 50mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start